Generic name: TAFENOQUINE SUCCINATE 150mg
Dosage form: tablet, film coated
Medically reviewed by Drugs.com. Last updated on Nov 16, 2020.
Tests to be Performed Prior to Treatment with KRINTAFEL
Recommended Dosage and Administration
The recommended dose of KRINTAFEL in patients aged 16 years and older is a single dose of 300 mg administered as two 150-mg tablets taken together. Coadminister KRINTAFEL on the first or second day of chloroquine therapy for acute P. vivax malaria [see Clinical Studies (14)].
Administer KRINTAFEL with food to increase systemic absorption [see Clinical Pharmacology (12.3)].
Swallow tablets whole. Do not break, crush, or chew the tablets.
In the event of vomiting within 1 hour after dosing, a repeat dose should be given. Re-dosing should not be attempted more than once.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Frequently Asked Questions
- What is the difference between Arakoda and Krintafel?
- How do you take Arakoda for the prevention of malaria?
- How do you take Krintafel?
More about Krintafel (tafenoquine)
- Side Effects
- During Pregnancy or Breastfeeding
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: antimalarial quinolines
- FDA Approval History
Other brands: Arakoda